Large-scale testing (Phase 3)Study completedNCT03358472
What this trial is testing
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
Who this might be right for
Head and Neck Cancer
Incyte Corporation 89